GlassScriptPhysician profile
Virginia C Nelson
NPI 1144323387
$836.42
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $42.14 · 2021: $290 · 2022: $83.97 · 2023: $144 · 2024: $90.07 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.80 | 2020-2025 | |
| Astellas Pharma US INC | $158.34 | 2021-2025 | Veozah |
| Mayne Pharma Commercial LLC | $95.94 | 2021-2025 | |
| Pfizer INC. | $59.25 | 2023-2024 | |
| Daiichi Sankyo INC. | $58.74 | 2021-2024 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.96 | 2022 | |
| Evofem Biosciences, INC. | $26.03 | 2021 | |
| Baxter Healthcare | $25.29 | 2025 | Tisseel |
| Exeltis, USA INC. | $24.26 | 2024 | Slynd |
| Myovant Sciences INC. | $14.90 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.67 | 2020 | |
| Novo Nordisk INC | $13.19 | 2023 | Wegovy |
| Coopersurgical, INC. | $12.14 | 2020 | |
| Therapeuticsmd, INC. | $11.48 | 2021 | |
| Minerva Surgical, INC | $11.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $5.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.